Shareholder Alert: Legal Actions on Recent Merger Developments by Monteverde & Associates

In the constantly evolving landscape of corporate mergers, shareholder rights and protections become increasingly significant. Recently, Monteverde & Associates PC, renowned for its adept handling of class action lawsuits, has announced a series of legal inquiries regarding notable mergers involving Corebridge Financial, RE/MAX Holdings, Selectis Health, and Apogee Therapeutics. This undertaking aims to solidify the interests of shareholders who might be affected by these significant corporate transactions.

Corebridge Financial and Equitable Holdings Merger

The proposed merger between Corebridge Financial, Inc. (NYSE: CRBG) and Equitable Holdings, Inc. is at the forefront of the inquiry. Upon the merger's completion, shareholders of Corebridge are set to gain ownership of roughly 51% of the new entity. The shareholder vote for this merger is slated for July 30, 2026, compelling investors to weigh their options carefully and consider their rights during the negotiation process. Monteverde & Associates is urging shareholders to assess their standing ahead of the decisive vote.

RE/MAX Holdings and The Real Brokerage Transaction

In another pivotal case, the legal team is scrutinizing the sale of RE/MAX Holdings, Inc. (NYSE: RMAX) to The Real Brokerage Inc. The proposed transaction outlines that RE/MAX shareholders could receive either 5.152 shares of the new company or a cash payment of $13.80 per share. Scheduled for a shareholder vote on August 14, 2026, this merger further emphasizes the necessity for shareholders to understand the implications of the offering and ensure that their interests are safeguarded.

Selectis Health's Acquisition Efforts

Furthermore, the firm is investigating the sale of Selectis Health, Inc. (OTCMKTS: GBCS) to Black Pearl Equities II, LLC. This transaction promises to provide shareholders with cash payments of $5.75 per share. As the tender offer expires on August 10, 2026, shareholders are presented with a limited timeframe to act, making the role of legal representation crucial during these negotiations.

Apogee Therapeutics and AbbVie Collaboration

Lastly, Monteverde & Associates is examining the merger of Apogee Therapeutics, Inc. (NASDAQ: APGE) with AbbVie Inc., where shareholders could expect to receive $135.11 per share in cash. This merger is likely to take center stage with an impending shareholder vote on August 11, 2026, encapsulating the urgency for shareholders to evaluate their positions thoroughly.

About Monteverde & Associates PC

Headquartered in the iconic Empire State Building in New York, Monteverde & Associates PC is recognized for successfully litigating numerous class-action lawsuits, recovering millions for shareholders across various sectors. Their commitment to shareholder rights establishes them as a leading firm in the realm of securities litigation. Speaking on the current inquiries, attorney Juan Monteverde emphasizes the importance of shareholders voicing their concerns and ensuring they are adequately informed of their rights.

Before enlisting the services of any law firm, it's prudent for investors to engage directly with legal professionals, inquiring about their experience with class action suits and their success rates.

Shareholders of Corebridge, RE/MAX, Selectis Health, and Apogee are encouraged to contact Monteverde & Associates for further information on these inquiries and the protections available to them.

Contact information:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
Email: [email protected]
Phone: (212) 971-1341

Whether a shareholder is facing a merger directly or simply interested in understanding their rights, now is the time to act. For more information, please visit Monteverde Law.